Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 2005

View Archived Issues

A phase I study reports antitumor activity for irofulven plus docetaxel

Peru-15 cholera vaccine found safe and immunogenic in adults and children

PTCA shows therapeutic potential for NASH

Promising results reported with a novel vaccine against Gram-positive bacteria

New data confirm the benefits of TH-070 in symptomatic BPH

Callisto reports plans for upcoming phase I/II ALL trial with annamycin

Callisto to evaluate atiprimod for treatment of myelodysplastic syndrome

NOX-B11: A novel ghrelin antagonist for obesity

Update on paricalcitol in the treatment of SHPT

DTwPHibHBV vaccine reported safe and immunogenic in humans

Phase II data on the effects of 4-OHT in cyclic mastalgia

Tanaproget shows efficacy as a novel contraceptive in healthy women

A drospirenone/ethinylestradiol combination shows promise in PMDD

Affitech enters licensing agreement for cancer-specific antibodies

NICE recommends use of Caelyx as second-line or subsequent treatment of advanced ovarian cancer

Par and Optimer enter development and collaboration agreement for PAR-101

Parent Project Muscular Dystrophy and Asklepios collaboration supports DMD gene therapy

Vitamin D3 analogue shows promise in a murine model of colitis-associated colon cancer

VistaGen Therapeutics receives NIH grant for preclinical studies of AV-101 for epilepsy

Inhaled insulin feasible and acceptable in patients with diabetes

Muraglitazar effective in randomized, double-blind trials in type 2 diabetes

Silodosin improves BPH symptoms in phase III trial

Recurrences unaffected by fenretinide in non-muscle invasive bladder cancer

Amitriptyline effective but limited by anticholinergic effects in interstitial cystitis

Novavax reports promising preclinical results with MNP technology

Patient enrollment in pivotal trial of Conor's CoStar drug-eluding stent commences

Norelin induces antitumor effects in patients with HDPC

Novel therapeutic agents for gastrointestinal disorders revealed in patents

Recent patents disclose novel analgesic agents

New therapeutics for cardiovascular diseases reported

GlaxoSmithKline submits BLA for Fluarix flu vaccine

Daiichi Suntory Pharma reports change in company name

Xenical receives positive opinion in E.U. for weight loss in adolescents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...